Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 53801 - 53825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Nitric Oxide	Approved Investigational	KDM4D	55693	upregulated	Nitric Oxide results in increased expression of KDM4D mRNA	11q21	A23353
Nitric Oxide	Approved Investigational	KDM7A	80853	upregulated	Nitric Oxide results in increased expression of KDM7A mRNA	7q34	A23353
Nitric Oxide	Approved Investigational	NDRG1	10397	upregulated	Nitric Oxide results in increased expression of NDRG1 mRNA	8q24.22	A23354
Nitric Oxide	Approved Investigational	NOS2	4843	upregulated	Nitric Oxide results in increased expression of NOS2 mRNA	17q11.2	A23355
Nitric Oxide	Approved Investigational	PHF8	23133	upregulated	Nitric Oxide results in increased expression of PHF8 mRNA	Xp11.22	A23353
Nitric Oxide	Approved Investigational	PMAIP1	5366	upregulated	Nitric Oxide results in increased expression of PMAIP1 mRNA	18q21.32	A23349
Nitric Oxide	Approved Investigational	PPM1D	8493	upregulated	Nitric Oxide results in increased expression of PPM1D mRNA	17q23.3	A23349
Nitric Oxide	Approved Investigational	PRDM2	7799	upregulated	Nitric Oxide results in increased expression of PRDM2 mRNA	1p36.21	A23353
Nitric Oxide	Approved Investigational	SETDB2	83852	upregulated	Nitric Oxide results in increased expression of SETDB2 mRNA	13q14.2	A23353
Nitric Oxide	Approved Investigational	SOD2	6648	upregulated	[NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which results in increased expression of SOD2 mRNA	6q25.3	A23352
Nitric Oxide	Approved Investigational	SUV39H2	79723	upregulated	Nitric Oxide results in increased expression of SUV39H2 mRNA	10p13	A23353
Nitric Oxide	Approved Investigational	TIMP2	7077	downregulated	Nitric Oxide results in decreased expression of TIMP2 mRNA	17q25.3	A23355
Nitric Oxide	Approved Investigational	TP53I3	9540	upregulated	Nitric Oxide results in increased expression of TP53I3 mRNA	2p23.3	A23349
Nitric Oxide	Approved Investigational	XIAP	331	downregulated	Nitric Oxide results in decreased expression of XIAP mRNA	Xq25	A23349
Nitroaspirin	Investigational	APOA1	335	upregulated	nitroaspirin results in increased expression of APOA1 mRNA	11q23.3	A20930
Nitroaspirin	Investigational	PON1	5444	upregulated	nitroaspirin results in increased expression of PON1 mRNA	7q21.3	A20930
Nitroglycerin	Approved Investigational	CXCL8	3576	upregulated	Nitroglycerin results in increased expression of CXCL8 mRNA	4q13.3	A23356
Nitroglycerin	Approved Investigational	EDN1	1906	downregulated	Nitroglycerin results in decreased expression of EDN1 mRNA	6p24.1	A22145
Nitroglycerin	Approved Investigational	HMOX1	3162	upregulated	Nitroglycerin results in increased expression of HMOX1 mRNA	22q12.3	A23356
Nitroglycerin	Approved Investigational	IL6	3569	upregulated	Nitroglycerin results in increased expression of IL6 mRNA	7p15.3	A23356
Nitroglycerin	Approved Investigational	MMP2	4313	upregulated	Nitroglycerin results in increased expression of MMP2 mRNA	16q12.2	A23357
Nitroglycerin	Approved Investigational	MMP7	4316	upregulated	Nitroglycerin results in increased expression of MMP7 mRNA	11q22.2	A23357
Nitroglycerin	Approved Investigational	MMP9	4318	upregulated	Nitroglycerin results in increased expression of MMP9 mRNA	20q13.12	A23357
Nitroglycerin	Approved Investigational	NOS2	4843	downregulated	Nitroglycerin results in decreased expression of NOS2 mRNA	17q11.2	A22145
Nitroprusside	Approved Investigational	BIRC5	332	downregulated	Nitroprusside results in decreased expression of BIRC5 mRNA	17q25.3	A23358

Displaying entries 53801 - 53825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability